Education
About Us
Working with TipRanks
Follow Us
Yunkang Group Limited (HK:2325)
:2325
2325 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$1.70 - HK$10.60
Previous CloseN/A
Volume10.00K
Average Volume (3M)480.16K
Market Cap
HK$1.14B
Enterprise ValueHK$4.53B
Total Cash (Recent Filing)HK$1.70B
Total Debt (Recent Filing)HK$1.18B
Price to Earnings (P/E)―
Beta0.19
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Jul 04, 2024Dividend Yield1.09%
Share Statistics
EPS (TTM)-1.44
Shares Outstanding621,250,500
10 Day Avg. Volume522,386
30 Day Avg. Volume480,161
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$4.00Price Target Upside118.58% Upside
Rating ConsensusHold
Number of Analyst Covering0
Yunkang Group Limited News
2325 FAQ
What was Yunkang Group Limited’s price range in the past 12 months?
Yunkang Group Limited lowest stock price was HK$1.70 and its highest was HK$10.60 in the past 12 months.
What is Yunkang Group Limited’s market cap?
Yunkang Group Limited’s market cap is HK$1.14B.
When is Yunkang Group Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Yunkang Group Limited’s earnings last quarter?
Currently, no data Available
Is Yunkang Group Limited overvalued?
According to Wall Street analysts Yunkang Group Limited’s price is currently Undervalued.
Does Yunkang Group Limited pay dividends?
Yunkang Group Limited pays a Annually dividend of HK$0.02 which represents an annual dividend yield of 1.09%. See more information on Yunkang Group Limited dividends here
What is Yunkang Group Limited’s EPS estimate?
Yunkang Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yunkang Group Limited have?
Yunkang Group Limited has 621,250,500 shares outstanding.
What happened to Yunkang Group Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Yunkang Group Limited?
Currently, no hedge funds are holding shares in HK:2325
Yunkang Group Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
HK$4.00 (118.58% Upside)
HK$4.00 (118.58% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-77.68%
12-Months-Change
Fundamentals
Return on Equity
-47.91%
Trailing 12-Months
Asset Growth
-23.34%
Trailing 12-Months
Company Description
Yunkang Group Limited
Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus, and nucleic acid tests for respiratory pathogens; genetic reproduction and screening tests; and routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. In addition, the company offers diagnostic testing services for financial institutions and insurance companies, including personalized diagnostic testing, medical report consultation, and hospital referral services; information technology, medical logistics, and medical equipment procurement; healthcare technology development; and project investment. It provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.
Yunkang Group Limited (2325) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
MicroPort CardioFlow Medtech Corp.
―
Beijing Airdoc Technology Co. Ltd. Class H
―
C-MER Eye Care Holdings Limited
―
Mega Genomics Limited
―